EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES - A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS

被引：0
|
作者：
Perkovic, Vlado [1 ]
Bain, Stephen [2 ]
Bakris, George [3 ]
Buse, John [4 ]
Idorn, Thomas [5 ]
Mahaffey, Kenneth [6 ]
Marso, Steven [7 ]
Nauck, Michael [8 ]
Pratley, Richard [9 ]
Rasmussen, Soren [5 ]
Rossing, Peter [10 ,11 ]
Tornoe, Karen [5 ]
Zinman, Bernard [12 ]
Mann, Johannes [13 ]
机构：
[1] UNSW Sydney, George Inst Global Hlth, Sydney, NSW, Australia
[2] Swansea Univ, Sch Med, Swansea, W Glam, Wales
[3] Univ Chicago Med, Chicago, IL USA
[4] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[5] Novo Nordisk AS, Site Soborg, Soborg, Denmark
[6] Stanford Sch Med, Stanford Ctr Clin Res, Stanford, CA 94305 USA
[7] Res Med Ctr, Kansas City, KS USA
[8] Ruhr Univ Bochum, St Josef Hosp, Diabet Ctr Bochum Hattingen, Bochum, Germany
[9] AdventHlth Translat Res Inst Metab & Diabet, Orlando, FL USA
[10] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[11] Univ Copenhagen, Copenhagen, Denmark
[12] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Mt Sinai Hosp, Toronto, ON, Canada
[13] Friedrich Alexander Univ Erlangen, Erlangen, Germany
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SaO010
引用
收藏
页码：338 / 338
页数：1
相关论文
共 50 条
  • [1] Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
    Shaman, Ahmed M.
    Bain, Stephen C.
    Bakris, George L.
    Buse, John B.
    Idorn, Thomas
    Mahaffey, Kenneth W.
    Mann, Johannes F. E.
    Nauck, Michael A.
    Rasmussen, Soren
    Rossing, Peter
    Wolthers, Benjamin
    Zinman, Bernard
    Perkovic, Vlado
    CIRCULATION, 2022, 145 (08) : 575 - 585
  • [2] The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
    Leiter, Lawrence A.
    Bain, Stephen C.
    Bhatt, Deepak L.
    Buse, John B.
    Mazer, C. David
    Pratley, Richard E.
    Rasmussen, Soren
    Ripa, Maria Sejersten
    Vrazic, Hrvoje
    Verma, Subodh
    DIABETES OBESITY & METABOLISM, 2020, 22 (09): : 1690 - 1695
  • [3] The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis
    Li, Ya-Kun
    Ma, Dong-Xia
    Wang, Zhi-Min
    Hu, Xiao-Fan
    Li, Shang-Lin
    Tian, Hong-Zhe
    Wang, Meng-Jun
    Shu, Yan-Wen
    Yang, Jun
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 102 - 111
  • [4] Glucagon-like peptide-1 drugs Are GLP-1 analogues affordable?
    Macaulay, Donald
    BRITISH MEDICAL JOURNAL, 2011, 342
  • [5] The Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide Improve Cardiovascular and Renal Outcomes Across Baseline Blood Pressure Categories: Analysis of LEADER and SUSTAIN 6
    Leiter, Lawrence A.
    Bain, Stephen
    Bhatt, Deepak L.
    Buse, John
    Mazer, C. David
    Pratley, Richard
    Lindberg, Soren
    Rasmussen, Soren
    Vrazic, Hrvoje
    Verma, Subodh
    CIRCULATION, 2018, 138
  • [6] EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER
    Perkovic, Vlado
    Bain, Stephen
    Bakris, George
    Buse, John
    Gondolf, Theis
    Idorn, Thomas
    Lausvig, Nanna
    Mahaffey, Kenneth
    Marso, Steven
    Nauck, Michael
    Pratley, Richard
    Rossing, Peter
    Zinman, Bernard
    Mann, Johannes
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [7] Neuroprotective effects of glucagon-like peptide-1 (GLP-1) analogues in epilepsy and associated comorbidities
    Manavi, Mohammad Amin
    NEUROPEPTIDES, 2022, 94
  • [8] Estimated GFR (eGFR) loss with glucagon-like peptide-1 (GLP-1) analogue treatment: data from SUSTAIN 6 and LEADER
    Perkovic, V.
    Bain, S. C.
    Bakris, G.
    Buse, J. B.
    Gondolf, T.
    Idorn, T.
    Lausvig, N.
    Mahaffey, K.
    Marso, S. P.
    Nauck, M. A.
    Pratley, R.
    Rossing, P.
    Zinman, B.
    Mann, J.
    DIABETOLOGIA, 2019, 62 : S484 - S485
  • [9] Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
    Lau, Jesper
    Bloch, Paw
    Schaffer, Lauge
    Pettersson, Ingrid
    Spetzler, Jane
    Kofoed, Jacob
    Madsen, Kjeld
    Knudsen, Lotte Bjerre
    McGuire, James
    Steensgaard, Dorte Bjerre
    Strauss, Holger Martin
    Gram, Dorte X.
    Knudsen, Sanne Moller
    Nielsen, Flemming Seier
    Thygesen, Peter
    Reedtz-Runge, Steffen
    Kruse, Thomas
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (18) : 7370 - 7380
  • [10] Can glucagon-like peptide-1(GLP-1) analogues make neuroprotection a reality?
    Maryna V.Basalay
    Sean M.Davidson
    Derek M.Yellon
    Neural Regeneration Research, 2020, 15 (10) : 1852 - 1853
12345